Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raltitrexed”

49 trials

Showing 20 of 49 results

Post-approval studies (Phase 4)UnknownNCT03196843
What this trial is testing

Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.

Who this might be right for
Head and Neck Squamous Cell Carcinoma
The First Affiliated Hospital of Dalian Medical University 202
Early research (Phase 1)Study completedNCT04761185
What this trial is testing

Raltitrexed in HIPEC

Who this might be right for
Colorectal CancerRaltitrexedHIPEC
Fudan University 30
Post-approval studies (Phase 4)UnknownNCT01959061
What this trial is testing

Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Metastatic
Nanjing Chia-tai Tianqing Pharmaceutical 320
Testing effectiveness (Phase 2)UnknownNCT03053167
What this trial is testing

Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

Who this might be right for
ColoRectal Cancer
China Medical University, China 100
Not applicableLooking for participantsNCT06408584
What this trial is testing

Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 25
Testing effectiveness (Phase 2)UnknownNCT05148143
What this trial is testing

RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor

Who this might be right for
Cholangioadenoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Testing effectiveness (Phase 2)UnknownNCT03585530
What this trial is testing

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

Who this might be right for
Esophagus Squamous Cell Carcinoma
Huai'an First People's Hospital 32
Testing effectiveness (Phase 2)UnknownNCT02376452
What this trial is testing

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

Who this might be right for
Colorectal Carcinoma
Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT02562599
What this trial is testing

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Who this might be right for
Nasopharyngeal Carcinoma
Hubei Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00004254
What this trial is testing

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)UnknownNCT03126071
What this trial is testing

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04499586
What this trial is testing

Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Recurrent Colorectal Cancer
Fudan University 30
Testing effectiveness (Phase 2)UnknownNCT04597970
What this trial is testing

TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC

Who this might be right for
Transarterial ChemoembolizationHepatocellular Carcinoma
Peking University Cancer Hospital & Institute 66
Large-scale testing (Phase 3)Study completedNCT00004920
What this trial is testing

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 256
Testing effectiveness (Phase 2)Study completedNCT02992886
What this trial is testing

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Who this might be right for
Rectal Neoplasms Malignant
Chinese Academy of Medical Sciences 68
Early research (Phase 1)Study completedNCT00003109
What this trial is testing

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Fox Chase Cancer Center 39
Testing effectiveness (Phase 2)UnknownNCT03392103
What this trial is testing

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Who this might be right for
Gastric Cancer
Zhongnan Hospital 48
Testing effectiveness (Phase 2)UnknownNCT01732380
What this trial is testing

A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer

Who this might be right for
Inoperable Esophageal Cancer Stage I-III
The First People's Hospital of Lianyungang 108
Large-scale testing (Phase 3)UnknownNCT02965248
What this trial is testing

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Who this might be right for
Locally Advanced Colorectal Cancer
Fudan University 147
Early research (Phase 1)Study completedNCT00003528
What this trial is testing

Raltitrexed in Treating Children With Refractory Acute Leukemia

Who this might be right for
Recurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid Leukemia
National Cancer Institute (NCI) 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation